Medicinal chemicals & botanical products Sample Contracts
EX-10.1 EMPLOYMENT AGREEMENT, dated as of April 18, 2007 (the "AGREEMENT"), between Synovics Pharmaceuticals, Inc., a Nevada corporation (the "COMPANY"), and David Coffin-Beach (the "EMPLOYEE"). The Company wishes to employ Employee, and Employee...Employment Agreement • April 24th, 2007 • Synovics Pharmaceuticals • Medicinal chemicals & botanical products • New York
EXHIBIT 10.2Registration Rights Agreement • June 4th, 2001 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products • New York
STOCK PURCHASE AGREEMENT BY AND AMONG TWINLAB CORPORATION, TWIN LABORATORIES INC., WILLIAM LOGUE, SHERI SEARSStock Purchase Agreement • September 4th, 1998 • Twinlab Corp • Medicinal chemicals & botanical products • New York
1 EXHIBIT 10(m)(v) SEVERANCE AGREEMENT AGREEMENT, by and between CN Biosciences, Inc., a Delaware corporation (the "Company"), and James G. Stewart (the "Executive"), dated as of February 27, 1997. WHEREAS, the Company wishes to provide for payment to...Severance Agreement • March 26th, 1997 • Cn Biosciences Inc • Medicinal chemicals & botanical products • California
LEASELease Agreement • January 13th, 1999 • Fountain Pharmaceuticals Inc • Medicinal chemicals & botanical products • Florida
1 ITEM 10.1 CONSULTING AGREEMENT THIS CONSULTING AGREEMENT, made and entered into this 19th day of April, 1996 by and between JACKIE R. SEE, M.D., hereinafter referred to as "CONSULTANT" and HARVARD SCIENTIFIC CORP., a Nevada corporation, hereinafter...Consulting Agreement • April 21st, 1997 • Harvard Scientific Corp • Medicinal chemicals & botanical products
ESCROW AGREEMENTEscrow Agreement • May 9th, 2006 • Argan Inc • Medicinal chemicals & botanical products • Connecticut
RECITALSPurchase Agreement • April 11th, 2002 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products • California
THIS WARRANT AND THE SHARES ISSUABLE UPON THE EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. EXCEPT AS OTHERWISE SET FORTH HEREIN OR IN A SECURITIES PURCHASE AGREEMENT DATED AS OF SEPTEMBER 10, 2004,...Warrant Agreement • September 16th, 2004 • Roo Group Inc • Medicinal chemicals & botanical products • New York
PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT Upexi, Inc.Security Agreement • May 15th, 2023 • Upexi, Inc. • Medicinal chemicals & botanical products
THIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [____] or his, her or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or November 8, 2023 (the “Initial Exercise Date”)1 and on or prior to 5:00 p.m. (New York City time) on May 16, 2028 (the “Termination Date”), but not thereafter, to subscribe for and purchase from Upexi, Inc., a Nevada corporation (the “Company”), up to [____] shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is being issued pursuant to that certain Placement Agency Agreement, dated as of May 12, 2023, by and among A.G.P./Alliance Global Partners, Paulson Investment Company, LLC and the Company.
TWIN LABORATORIES INC., as Issuer, and THE GUARANTORS NAMED HEREIN and STATE STREET BANK AND TRUST COMPANY, as Trustee FIRST SUPPLEMENTAL INDENTURE Dated as of December 1, 1997 to INDENTURE Dated As of May 7, 1996 ------------ 10-1/4% Senior...First Supplemental Indenture • March 17th, 1998 • Twinlab Corp • Medicinal chemicals & botanical products • New York
COMMON STOCK PURCHASE WARRANT UPEXI, INC.Common Stock Purchase Warrant • April 24th, 2025 • Upexi, Inc. • Medicinal chemicals & botanical products • New York
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, GSR Strategies LLC or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on the seven (7) year anniversary of the date hereof (the “Termination Date”) but not thereafter, to subscribe for and purchase from Upexi, Inc., a Nevada corporation (the “Company”), up to 2,192,982 shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). The Warrant Shares are being issued pursuant to the Asset Management Agreement, dated on or around April 21 , 2025.
DEFINITIVE SUBSCRIPTION AGREEMENT ----------------------------------------Subscription Agreement • February 2nd, 2007 • Synovics Pharmaceuticals • Medicinal chemicals & botanical products • New York
EXHIBIT HStock Purchase Agreement • April 11th, 2002 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products • California
EXHIBIT 10.34 LYNX THERAPEUTICS, INC. LOAN AND SECURITY AGREEMENT This LOAN AND SECURITY AGREEMENT is entered into as of October 23, 2002, by and between COMERICA BANK-CALIFORNIA ("Bank") and LYNX THERAPEUTICS, INC. ("Borrower").Loan and Security Agreement • November 13th, 2002 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products • California
March 20, 1998 NaPro BioTherapeutics, Inc. 6304 Spine Road Unit A Boulder, Colorado 80301 Attn: Vice President and Chief Financial Officer Gentlemen: Reference is made to (i) the Note Purchase Agreements (the "Purchase Agreements") dated as of May 30,...Note Purchase Agreement • April 8th, 1998 • Napro Biotherapeutics Inc • Medicinal chemicals & botanical products
1 EXHIBIT 4(i)8 THIS WARRANT AND THE SHARES ISSUABLE UPON THE EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. EXCEPT AS OTHERWISE SET FORTH HEREIN OR IN A SECURITIES PURCHASE AGREEMENT DATED AS OF AUGUST...Warrant Agreement • August 16th, 2001 • Infotopia Inc • Medicinal chemicals & botanical products • New York
EXHIBIT GOption Agreement • December 15th, 1998 • Hauser Chemical Research Inc • Medicinal chemicals & botanical products • Colorado
AGREEMENT ANDMerger Agreement • March 30th, 2001 • Bio Technology General Corp • Medicinal chemicals & botanical products • New York
Common Stock ($0.01 Par Value)Underwriting Agreement • February 18th, 2005 • Neose Technologies Inc • Medicinal chemicals & botanical products • New York
SUPPLEMENTAL INDENTURE ----------------------Supplemental Indenture • March 18th, 1999 • Global Health Sciences Inc • Medicinal chemicals & botanical products • New York
EXHIBIT 16.1 SHARE PURCHASE AGREEMENT THIS AGREEMENT made the 31st day of March, 2004. BETWEEN: BIO-ONE CORPORATIONShare Purchase Agreement • April 15th, 2004 • Bio One Corp • Medicinal chemicals & botanical products • Ontario
ARTICLE I DEFINITIONSSecurities Purchase Agreement • January 2nd, 2004 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products • New York
RECITALSPurchase and Sale Agreement • March 16th, 2006 • Bionutrics Inc • Medicinal chemicals & botanical products
INDENTUREIndenture • July 10th, 1998 • D&f Industries Inc • Medicinal chemicals & botanical products • New York
Exhibit 1.1 MAXIM PHARMACEUTICALS, INC. 2,500,000 Shares of Common Stock Underwriting AgreementUnderwriting Agreement • February 17th, 2000 • Maxim Pharmaceuticals Inc • Medicinal chemicals & botanical products • New York
Exhibit 10.6 THIS LEASE is made on 20 August 2001 BETWEEN (1) ELDERWALK LIMITED (company number 3088546 England) whose registered office is at 20 Albert Embankment, London, SEl 7TJ ("Landlord") (2) ONLINE ADVISORY LIMITED company number (03812364)...Lease Agreement • November 13th, 2001 • Glengarry Holdings LTD • Medicinal chemicals & botanical products
RECITALSMerger Agreement • March 27th, 1997 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products • Delaware
EXECUTION VERSION REDACTED - AS FILED [PORTIONS OF THIS EXHIBIT HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT] Brackets "[ ]" ARE USED TO INDICATE WHERE A PORTION OF THIS EXHIBIT HAS BEEN OMITTED. CONFIDENTIAL TREATMENT HAS BEEN...Asset Purchase Agreement • March 31st, 2006 • Pacifichealth Laboratories Inc • Medicinal chemicals & botanical products • Texas
Exhibit 10-3 ------------ AMENDED AND RESTATED STOCKHOLDERS AGREEMENT ------------------------------------------- THIS AMENDED AND RESTATED STOCKHOLDERS AGREEMENT (this "Agreement") is made and entered into as of January 31, 1995, by and among...Stockholders Agreement • January 28th, 1998 • Nutraceutical International Corp • Medicinal chemicals & botanical products • New York
AGREEMENTRights Agreement • September 14th, 2006 • Synovics Pharmaceuticals • Medicinal chemicals & botanical products • Delaware
JOINT FILING AGREEMENTJoint Filing Agreement • December 27th, 2002 • Takara Bio Inc • Medicinal chemicals & botanical products
The undersigned parties hereby agree that the Schedule 13D filed herewith (and any amendments thereto) relating to the stock of Lynx Therapeutics, Inc. is being filed jointly with the Securities and Exchange Commission pursuant to Rule 13d-1(f) under the Securities Exchange Act of 1934, as amended, on behalf of each such person.
Exhibit 2.3 ASSET PURCHASE AGREEMENT This ASSET PURCHASE AGREEMENT (the "Agreement") is made as of November 6, 2003 by and among OPTIGENEX INC., a Delaware corporation ("Buyer" or "OPTIGENEX"), CampaMed LLC, a limited liability company organized under...Asset Purchase Agreement • April 15th, 2005 • Optigenex Inc. • Medicinal chemicals & botanical products • New York
9/15/97 Draft - Subject to client review 2,500,000 SHARES OF COMMON STOCK MAXIM PHARMACEUTICALS, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • September 18th, 1997 • Maxim Pharmaceuticals Inc • Medicinal chemicals & botanical products
ARTICLE.1 PURCHASE AND SALE OF ASSETS........................ 5 ARTICLE.2 CLOSING AND PURCHASE PRICE......................... 6 ARTICLE.3 REPRESENTATIONS AND WARRANTIES OF THE SELLER....... 8 ARTICLE.4 REPRESENTATIONS AND WARRANTIES OF...Asset Purchase Agreement • April 6th, 2004 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products